Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
letter
. 2020 Jun 15;2(3):100158. doi: 10.1016/j.ajogmf.2020.100158

Reply

Rupsa C Boelig 1, Federica Bellussi 1, Vincenzo Berghella 1
PMCID: PMC7295502  PMID: 32838263

We thank Drs Lagrew and Shields for their interest and inquiry. We apologize that not all the appropriate references were included in our manuscript. There are a number of different publications that have demonstrated aerosolization with cough, and many are summarized in a recent commentary by Brosseau.1 We have listed some key references below, which identify aerosolization in cough.2, 3, 4, 5, 6, 7 In addition, it is important to consider that aerosolization in the setting of disease transmission is not equivalent across all diseases, but that does not mean it is nonexistent. For example, in tuberculosis (TB), the classic example of a disease with the risk of airborne transmission, the bacteria remain viable in the air for a long time. Increasing number of studies on animals and humans have reported on the role of close-range aerosol transmission by inhalation for influenza and coronaviruses.8, 9, 10 Although airborne aerosolization risk of influenza and coronaviruses is not similar to that of TB, the risk of airborne spread remains, especially when considering prolonged close-range contact, as in the second stage of labor.

Our study also discusses the issue of limited resources and the actions the healthcare system must take in dealing with patients in the second stage of labor. Things to consider include ability to test patients for severe acute respiratory syndrome coronavirus 2. With recent advances, there is now rapid testing available that would allow for testing of all admissions to labor and delivery. This allows healthcare workers to reserve the use of limited personal protective equipment (PPE) for the confirmed cases of coronavirus disease 2019 (COVID-19). The test also reassures other laboring patients that they are COVID-19 negative. All forms of PPE are risk reducing but not risk eliminating. We present what best practices should be and recognize that best practices may not always be possible, especially in the real world where resources are limited. However, we strive to advocate, and to provide data to support, policies that will promote not only patient safety but also a safe work environment for healthcare providers.

The second stage of labor presents a unique clinical scenario of close contact (<6 feet), involving deep and heavy breathing of a patient. Despite both healthcare workers and patients wearing masks, there can be scenarios allowing the possibility of droplet and aerosol transmission, for example, close contact with a patient who has trouble keeping the mask on.3 In the setting of a pandemic, it is important to consider that PPE and healthcare workers are limited resources. Knowing this, we continue to advocate for the consideration of the second stage of labor as a high-risk scenario for both droplet and aerosol transmission and advocate that the healthcare workers should be adequately protected.11, 12, 13, 14

Footnotes

This paper is part of a supplement that represents a collection of COVID-related articles selected for publication by the editors of AJOG MFM without additional financial support.

R.C.B. was supported by a PhRMA Foundation Faculty Development Award in Clinical and Translational Pharmacology.

The authors report no conflict of interest.

References

  • 1.Brosseau L. Commentary: COVID-19 transmission messages should hinge on science. Center for Infectious Disease Research and Policy. 2020. http://www.cidrap.umn.edu/news-perspective/2020/03/commentary-covid-19-transmission-messages-should-hinge-science Available at:
  • 2.Yang S., Lee G.W., Chen C.M., Wu C.C., Yu K.P. The size and concentration of droplets generated by coughing in human subjects. J Aerosol Med. 2007;20:484–494. doi: 10.1089/jam.2007.0610. [DOI] [PubMed] [Google Scholar]
  • 3.Milton D.K., Fabian M.P., Cowling B.J., Grantham M.L., McDevitt J.J. Influenza virus aerosols in human exhaled breath: particle size, culturability, and effect of surgical masks. PLoS Pathog. 2013;9 doi: 10.1371/journal.ppat.1003205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Lindsley W.G., Pearce T.A., Hudnall J.B. Quantity and size distribution of cough-generated aerosol particles produced by influenza patients during and after illness. J Occup Environ Hyg. 2012;9:443–449. doi: 10.1080/15459624.2012.684582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Lindsley W.G., Blachere F.M., Thewlis R.E. Measurements of airborne influenza virus in aerosol particles from human coughs. PLoS One. 2010;5 doi: 10.1371/journal.pone.0015100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Noti J.D., Lindsley W.G., Blachere F.M. Detection of infectious influenza virus in cough aerosols generated in a simulated patient examination room. Clin Infect Dis. 2012;54:1569–1577. doi: 10.1093/cid/cis237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Blachere F.M., Lindsley W.G., Pearce T.A. Measurement of airborne influenza virus in a hospital emergency department. Clin Infect Dis. 2009;48:438–440. doi: 10.1086/596478. [DOI] [PubMed] [Google Scholar]
  • 8.Tellier R., Li Y., Cowling B.J., Tang J.W. Recognition of aerosol transmission of infectious agents: a commentary. BMC Infect Dis. 2019;19:101. doi: 10.1186/s12879-019-3707-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Cowling B.J., Ip D.K., Fang V.J. Aerosol transmission is an important mode of influenza A virus spread. Nat Commun. 2013;4:1935. doi: 10.1038/ncomms2922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.van Doremalen N., Bushmaker T., Morris D. Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1. medRxiv. 2020. https://www.medrxiv.org/content/10.1101/2020.03.09.20033217v2 Available at: Accessed June 29, 2020. [DOI] [PMC free article] [PubMed]
  • 11.Berghella V. Now!: protection for obstetrical providers and patients. Am J Obstet Gynecol MFM. 2020;2:100109. doi: 10.1016/j.ajogmf.2020.100109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Breslin N., Baptiste C., Miller R. Coronavirus disease 2019 in pregnancy: early lessons. Am J Obstet Gynecol MFM. 2020;2:100111. doi: 10.1016/j.ajogmf.2020.100111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Breslin N., Baptiste C., Gyamfi-Bannerman C. COVID-19 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals. Am J Obstet Gynecol MFM. 2020;2:100118. doi: 10.1016/j.ajogmf.2020.100118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Boelig R.C., Manuck T., Oliver E.A. Labor and delivery guidance for COVID-19. Am J Obstet Gynecol MFM. 2020;2:100110. doi: 10.1016/j.ajogmf.2020.100110. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Obstetrics & Gynecology Mfm are provided here courtesy of Elsevier

RESOURCES